COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine-Reference-Cited by-同舟云学术

COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine

Published:2022-03 Issue: Volume:56 Page:92-99
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Govind Risha^ORCID,de Freitas Daniela Fonseca^ORCID,Pritchard Megan,Khondoker Mizanur^ORCID,Teo James T.^ORCID,Stewart Robert,Hayes Richard D.^ORCID,MacCabe James H.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference30 articles.

1. Antipsychotic-induced weight gain: A comprehensive research synthesis;Allison;Am. J. Psychiatry,1999

2. ‘Clozapine in the time of COVID-19’, Clinical Psychopharmacology and Neuroscience;Boland;Korean College of Neuropsychopharmacology,2020

3. Clozapine prescribing in COVID-19 positive medical inpatients: a case series;Butler,2020

4. Clozapine and all-cause mortality in treatment-resistant schizophrenia: a historical cohort study;Cho,2018

5. The incidence and all-cause mortality of pneumonia in patients with schizophrenia: A nine-year follow-up study;Chou;J. Psychiatr. Res.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional differences in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis;European Neuropsychopharmacology;2024-03

2. Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics;International Clinical Psychopharmacology;2024-01-22

3. COVID-19 pandemic in the intensive care unit: Psychological implications and interventions, a systematic review;World Journal of Psychiatry;2023-04-19

4. Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives;Schizophrenia Bulletin;2022-10-15

5. THE EFFECT OF CLOZAPINE USE ON THE RISK AND OUTCOME OF COVID-19 IN PATIENTS WITH SCHIZOPHRENIA;Archives of Neuropsychiatry;2022